Qube Research & Technologies (QRT)
BIAF icon

Qube Research & Technologies (QRT)’s bioAffinity Technologies BIAF Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$82 – 3332
2024
Q2 		$82 Hold
1
– – ﹤0.01% 3448
2024
Q1 		$77 Hold
1
– – ﹤0.01% 4195
2023
Q4 		$57 Hold
1
– – ﹤0.01% 4058
2023
Q3 		$46 Buy
+1
New +$51 ﹤0.01% 3820

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIAF Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of bioAffinity Technologies (BIAF) in Q3 2024, closing a stake of 1 share — an estimated $82 sold.

Qube Research & Technologies (QRT) first reported a position in BIAF in Q3 2023 and held it in 4 quarters. The position peaked at $82 in Q2 2024. 14 funds tracked by Wall St. Rank hold BIAF as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining bioAffinity Technologies position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 bioAffinity Technologies share in Q3 2024, an estimated $82.
  • Qube Research & Technologies (QRT) first reported a position in bioAffinity Technologies in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s bioAffinity Technologies position peaked at $82 in Q2 2024.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.